arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Celcuity Inc.

CELC Health Care Medical Specialities
$95.70
Today
as of Sep 4, 16:47 ET
Last 30 days +16.32% Jul 27 → Sep 04
$81.14 $85.24 $89.35 $93.46 $97.56 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$95.83
High
$97.25
Low
$94.55
Volume
$515,509
Avg Vol
$1M
Mkt Cap
$4.4B
P/E (TTM)
—
Beta
—
52w High
$151.02
52w Low
$44.42
Div Yield
—
Shares Out
$49M

Recent Press Releases & News last 60 days · 19 items

Sep 1 · 12:30 PR GlobeNewswire
Celcuity To Participate in Upcoming Investor Conferences
Aug 27 · 20:27 Insider Monkey
Celcuity (CELC): Landmark Approval Collides With A Costly Launch
Aug 26 · 12:59 MT Newswires
Celcuity Submits Supplemental NDA for REVTORPYK in PIK3CA-Mutant Breast Cancer
▸ Show all 19 press releases & news Free account →

Overview

52-week range
$44
$151
48% of range
Avg surprise (last 3)
+1.1%
Avg reaction (last 2)
+4.3%
100% positive
Latest IV / EM
48%
EM ±7.4% · $95 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.44$-1.22$-0.99$-0.77$-0.55 Actual $-0.55Actual $-0.66Actual $-0.83Actual $-0.64Actual $-0.62Actual $-0.70Actual $-0.86Est $-0.95Actual $-1.04Est $-0.90Actual $-0.92Actual $-0.97Est $-1.07Actual $-1.44 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-79M$-67M$-55M$-43M$-31M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-1.44 — — — — financials
Thu May 14, 2026Mar/2026 $-0.97 $-1.07 +9.3% -12.8% +8.2% earnings
Tue Sep 30, 2025Sep 2025 $-0.92 — — — — financials
Thu Aug 14, 2025Jun/2025 $-1.04 $-0.90 -15.6% — — earnings
Wed May 14, 2025Mar/2025 $-0.86 $-0.95 +9.5% — +0.4% earnings
Mon Sep 30, 2024Sep 2024 $-0.70 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.62 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.64 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.83 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.66 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.55 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-66M$-51M—$-43M$-44M$-36M—$-30M
Net income$-79M$-53M—$-44M$-45M$-37M—$-30M
EPS (diluted)$-1.44$-0.97—$-0.92$-1.04$-0.86—$-0.70

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$182M$145M$166M$74M$46M$16M$23M$13M
Inventory————————
Total current assets$776M$409M$466M$475M$183M$218M$245M$272M
Total assets$828M$410M$467M$476M$184M$218M$245M$273M
Long-term debt$0$138M—$137M$106M$105M—$105M
Total liabilities$841M$357M$366M$359M$139M$131M$130M$123M
Total equity$-13M$54M$101M$117M$44M$87M$116M$150M

Implied volatility — last 90 days

45%70%94%119%143% Jun 07 — IV 79% · EM ±10.9%Jun 08 — IV 79% · EM ±10.4%Jun 09 — IV 76% · EM ±9.6%Jun 10 — IV 77% · EM ±9.2%Jun 11 — IV 72% · EM ±8.0%Jun 12 — IV 72% · EM ±7.4%Jun 15 — IV 82% · EM ±5.9%Jun 16 — IV 143% · EM ±8.5%Jun 17 — IV 114% · EM ±4.7%Jun 19 — IV 68% · EM ±15.0%Jun 22 — IV 74% · EM ±15.4%Jun 23 — IV 71% · EM ±14.5%Jun 24 — IV 70% · EM ±14.1%Jun 25 — IV 77% · EM ±15.1%Jun 26 — IV 78% · EM ±15.0%Jun 29 — IV 82% · EM ±14.6%Jun 30 — IV 76% · EM ±13.1%Jul 01 — IV 70% · EM ±11.7%Jul 02 — IV 77% · EM ±12.5%Jul 03 — IV 80% · EM ±12.5%Jul 06 — IV 66% · EM ±9.1%Jul 07 — IV 71% · EM ±9.3%Jul 08 — IV 86% · EM ±10.8%Jul 09 — IV 90% · EM ±10.7%Jul 10 — IV 86% · EM ±9.5%Jul 13 — IV 113% · EM ±9.4%Jul 14 — IV 96% · EM ±6.9%Jul 15 — IV 130% · EM ±7.7%Jul 16 — IV 134% · EM ±5.6%Jul 20 — IV 78% · EM ±18.5%Jul 21 — IV 75% · EM ±17.5%Jul 22 — IV 75% · EM ±17.2%Jul 23 — IV 71% · EM ±16.0%Jul 24 — IV 74% · EM ±16.5%Jul 27 — IV 73% · EM ±15.3%Jul 28 — IV 76% · EM ±15.5%Jul 29 — IV 77% · EM ±15.5%Jul 30 — IV 77% · EM ±15.1%Jul 31 — IV 72% · EM ±13.8%Aug 03 — IV 79% · EM ±14.0%Aug 04 — IV 81% · EM ±14.0%Aug 05 — IV 82% · EM ±13.7%Aug 06 — IV 80% · EM ±13.0%Aug 07 — IV 82% · EM ±12.8%Aug 10 — IV 82% · EM ±11.3%Aug 11 — IV 84% · EM ±11.0%Aug 12 — IV 79% · EM ±9.9%Aug 13 — IV 80% · EM ±9.4%Aug 14 — IV 66% · EM ±7.3%Aug 17 — IV 79% · EM ±6.6%Aug 18 — IV 64% · EM ±4.6%Aug 19 — IV 67% · EM ±4.0%Aug 20 — IV 84% · EM ±3.5%Aug 24 — IV 59% · EM ±12.3%Aug 25 — IV 56% · EM ±11.5%Aug 26 — IV 46% · EM ±9.2%Aug 27 — IV 59% · EM ±11.5%Aug 28 — IV 48% · EM ±9.3%Aug 31 — IV 53% · EM ±9.4%Sep 01 — IV 49% · EM ±8.4%Sep 02 — IV 55% · EM ±9.1%Sep 03 — IV 52% · EM ±8.4%Sep 04 — IV 48% · EM ±7.4%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in